The transition of Medicaid programs from fee-for-service (FFS) reimbursement to managed care (MMC) increased the probability of children being treated for asthma and attention deficit hyperactivity disorder (ADHD). ADHD treatment in children increased by 26.6%, and asthma treatment in children increased by 29.9%. These findings were reported in “Exploding Asthma and ADHD Caseloads: The Role of Medicaid Managed Care” by Anna Chorniy, Janet Currie, and Lyudmyla Sonchak. The researchers analyzed data for a 60% random sample of all children on Medicaid in South Carolina during the period of 2004 to 2015. Between 2007 and 2008, South . . .